demanding mental performance takes place. In certain cells of the nervous system, EPO is produced together with the corresponding erythropoietin receptors (EPOR). The hormone can bind through the receptor on the [...] way for more targeted therapeutic use of EPO signaling pathways – for example in diseases associated with cognitive impairment or in rehabilitation after brain damage. The study shows impressively that the

Mannheim Medical Faculty of the University of Heidelberg. Partners in the SFB/TRR 265, which is funded with around 16.3 million euros, are the Charité and the Technical University of Dresden as co-applicants [...] Neuropsychology and Clinical Psychology at the CIMH. The DFG is funding the Collaborative Research Center with approximately 17.5 million euros.

zu verhindern. Veröffentlichung: “Microstructural White Matter Alterations in Men With Alcohol Use Disorder and Rats With Excessive Alcohol Consumption During Early Abstinence”, JAMA Psychiatry. 2019 doi:10

unique molecular process that is not present in the consolidation of weak fear memories. In experiments with mice, they discovered that experiencing an aversive event leads to two phases of high concentration [...] prevents very strong fear memories from being formed. These results suggest that the brain is equipped with a mechanism that fine-tunes the strength of the memory of an aversive event – a new finding. Specifically

Centre Rostock report in the Journal of ECT on a total of 32 children and adolescents who were treated with electroconvulsive therapy at the three clinics. All of the children had severe mental illnesses and [...] centres than the three clinics mentioned in Germany offered ECT as a treatment option for adolescents with severe depressive and psychotic disorders. There are often very long waiting times for ECT and hardly

Cognition Research ”. How memory is formed Oliveira and her research group are primarily concerned with how memory is formed in the brain and how memories are stored over time. The goal of the effort is

g achievements in the preclinical and translational development of pharmacotherapies for patients with alcohol addiction. Prof. Spanagel has been involved in addiction research for over 30 years and is

administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. In: Molecular Psychiatry

quantities with medication." Mann also emphasizes the concrete benefits of the approach for those affected, their personal environment and society: "The study data show that those affected with reduced

Veröffentlichung: Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders , Nature Neuroscience, DOI: 10.1038/s41593-018-0275-1. Weitere Meldungen des